ArticleFrontiers in pharmacology2021

Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma.

Anqi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.